Skip to content

Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study)

Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students: a Multicenter Randomized Controlled Trial (PROMES-U Study)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06078007
Acronym
PROMES-U
Enrollment
600
Registered
2023-10-11
Start date
2024-10-25
Completion date
2025-11-30
Last updated
2024-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depressive Symptoms

Brief summary

Background: Symptoms of depression and anxiety are prevalent among Spanish university students. Minimally guided online interventions have shown promise in reducing symptomatology and preventing increased mental distress. There is a need to evaluate the effectiveness of guided preventive mental health interventions for depression and anxiety in university students. Methods: two-arm multicenter randomized controlled trial (RCT), addressed to undergraduate students from 6 public universities with symptoms of depression and/or anxiety. Students will be evaluated through an online survey assessing mental health problems, use of mental health services, sociodemographic variables, self-perceived health, childhood and adolescent adversities, recent stressful events, social networks, personality and university experiences. A total of 600 students will be randomly assigned to: intervention group (guided E-health prevention intervention) or control group (treatment as usual with self-monitoring). The intervention, in app format, is based on principles of cognitive behavioral therapy, includes weekly feedback based on content and participation from a psychologist and self-monitoring. Assessments will take place post-intervention (up to 6 weeks), at 6 months and 12 months after randomization. The primary outcome will be the reduction of depressive or anxiety symptoms post-intervention, assessed with the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS). Secondary outcomes of the RCT will be mental wellbeing, academic stress, comorbid symptoms, and adherence. Analyses will be conducted on an intention-to-treat and per protocol basis. Discussion: The results of the PROMES-U RCT will provide valuable information on a guided preventive online intervention that could be delivered in the campus context. In addition, results will provide information on the positive impact of the intervention on other relevant factors involved in mental health among university students.

Interventions

BEHAVIORALMyMoodCoach

The MyMoodCoach prevention intervention is an evidence-based online intervention based on cognitive-behavioral therapy principles such as behavioral activation, problem solving and challenging negative thoughts.

Sponsors

Hospital del Mar Research Institute (IMIM)
CollaboratorOTHER
Universitat Jaume I
CollaboratorOTHER
Universidad Miguel Hernandez de Elche
CollaboratorOTHER
Universitat Pompeu Fabra
CollaboratorOTHER
Universidad de Zaragoza
CollaboratorOTHER
University of Malaga
CollaboratorOTHER
Instituto de Salud Carlos III
CollaboratorOTHER_GOV
University of the Balearic Islands
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible participants are all undergraduate students at the 6 participating universities and students followed in the PROMES-U observational study * Having 18 years of age or more * Having literacy in Spanish * Having access to a smartphone (Android or Apple) * With mild or moderate depression and/or anxiety symptoms screened (i.e., depression (5≤ (PHQ-9) ≤14); and/or anxiety (5≤ GAD-7 ≤14).

Exclusion criteria

* Moderately severe or severe depression and/or anxiety (i.e., PHQ-9≥15 and/or GAD-7≥15) * High suicide risk * A history of severe psychiatric disorder (e.g., bipolar, psychosis) * Being on mental health treatment (i.e., medication, psychotherapy or other intervention) Students with high suicide risk will receive a clinical alert recommending them to visit a specialist and a list of available mental health resources.

Design outcomes

Primary

MeasureTime frameDescription
Change of depressive symptomsUp to 6 weeks, at 6 months and 12 months after randomizationThe primary outcome will be the change of depressive symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Patient Health Questionnaire-9 (PHQ-9) and the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The PHQ-9 range from 0 to 27, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe depression.
Change of anxiety symptomsUp to 6 weeks and at 6 months and 12 months post randomizationThe primary outcome will be the change of anxiety symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Generalized Anxiety Disorder -7 (GAD-7) he Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The GAD-7 range from 0 to 21, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe anxiety.

Countries

Spain

Contacts

Primary ContactJordi Alonso
jalonso@researchmar.net93 316 07 60
Backup ContactPROMES-U Study
promes@researchmar.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026